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Abstract
The factors defining the correct folding and stability of integral membrane proteins are
poorly understood. Folding of only a few select membrane proteins has been scrutinised,
leaving considerable deficiencies in knowledge for large protein families, such as G protein
coupled receptors (GPCRs). Complete reversible folding, which is problematic for any
membrane protein, has eluded this dominant receptor family. Moreover, attempts to recover
receptors from denatured states are inefficient, yielding at best 40–70% functional protein.
We present a method for the reversible unfolding of an archetypal family member, the β1-
adrenergic receptor, and attain 100% recovery of the folded, functional state, in terms of
ligand binding, compared to receptor which has not been subject to any unfolding and
retains its original, folded structure. We exploit refolding on a solid support, which could
avoid unwanted interactions and aggregation that occur in bulk solution. We determine the
changes in structure and function upon unfolding and refolding. Additionally, we employ a
method that is relatively new to membrane protein folding; pulse proteolysis. Complete
refolding of β1-adrenergic receptor occurs in n-decyl-β-D-maltoside (DM) micelles from a
urea-denatured state, as shown by regain of its original helical structure, ligand binding and
protein fluorescence. The successful refolding strategy on a solid support offers a defined
method for the controlled refolding and recovery of functional GPCRs and other membrane
proteins that suffer from instability and irreversible denaturation once isolated from their
native membranes.
Introduction
A central feature of biological activity is the correct folding of proteins into their functional
states. Integral membrane proteins have been largely overlooked in the extensive investigations
levelled at understanding this folding process. Biophysical studies in vitro are currently the
method of choice for elucidating molecular level mechanistic detail [1–6] and these are being
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complemented by studies using cellular membrane extracts to capture the additional cellular
machineries involved in correct membrane protein folding in vivo [7–10]. One of the largest
knowledge gaps lies with biophysical studies of transmembrane helical proteins and there is a
dearth of information on many large membrane protein families. A case in point are GPCRs.
These constitute the largest family of membrane receptors, with over 800 human GPCRs iden-
tified, and are the focus of considerable research and industrial interest [11, 12]. The primary
function of GPCRs is to respond to extracellular stimuli and activate an array of intracellular
signalling pathways through their interaction with numerous G protein subtypes as well as
through G-protein independent pathways, often in a ligand-specific manner [13, 14]. The lack
of in vitro folding information on this particular protein class has significant ramifications. It
impacts directly upon achieving and maintaining a correctly folded, functional structure for
the plethora of biophysical, biochemical and structural work aimed at ascertaining functional
mechanisms for GPCRs. Obtaining sufficient quantities of properly folded GPCRs for in vitro
structural and functional studies has proven tremendously difficult, not least due to the poor
long-term stability of the receptors in detergents and associated loss of structure and function.
These practical issues, together with the inherent importance of understanding folding, have
highlighted the significance of investigating GCPR refolding and stability. One of the most
promising advances in this area has been the use of columns as solid supports for recovering
functional GPCR from inclusion bodies, using SDS to solubilise the inclusion bodies generally
with amphipols or bicelles to recover folded protein [15–19]. The most successful cases result
in ~40–70% recovery of functional protein. Solubilisation of inclusion bodies in urea gives
much lower yields of 25%. The extent of denaturation of the SDS or urea-solubilised state has
not been assessed in detail—these denaturants could in fact be primarily solubilising protein
that is already largely folded from the inclusion bodies, so little or no refolding is required. Nor
have there been any reports on the controlled, reversible unfolding and refolding a receptor.
Reversible unfolding has however, been demonstrated for several other α-helical membrane
proteins from different protein classes including diacylglycerol kinase (DGK) [20], the potas-
sium channel, KscA [21, 22], the galactose transporter, GalP [3] and the small multidrug resis-
tance transporter, EmrE [1].
Here, we present a systematic folding study of the thermostabilised turkey β1-adrenergic
receptor (β1AR-m23) [23, 24], using urea and SDS denaturants. This mutant offers an exciting
opportunity for folding studies as the increased stability makes refolding a viable prospect. We
compare refolding in detergent micelles composed of DM in bulk solution with a solid support.
The latter approach gives unprecedented reversible refolding of the GPCR, from a urea-dena-
tured state, with a 100% yield. Although interactions with other lipids or proteins in native
membranes may be important for the functional folded state of GPCRs in vivo, here we study
the receptor in isolation and address function with respect to ligand binding only. It is vital to
attain complete recovery of such function as membrane proteins are notorious for perturba-
tions of ligand binding constants and reduced stability when solubilised in detergents, even
without any refolding.
Materials and Methods
Materials
DM was purchased from Anatrace Inc. (Maumee, OH, USA). DMPC was from Avanti Polar
Lipids Inc (Alabaster, Al). CHAPS was from Calbiochem. [3H] (-) dihydroalprenolol (DHA)
was from Amersham. Ni-NTA agarose beads were from Qiagen. All other chemicals were of
the highest grade and purchased from Sigma-Aldrich, unless stated otherwise.
Reversible Refolding of a G-Protein Coupled Receptor
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Abbreviations: β1AR-m23, thermostabilised β1-
adrenergic receptor; CD, circular dichroism; CHAPS,
3-[(3-Cholamidopropyl)dimethylammonio]-1-
propanesulfonate; CHAPSO, 3-[(3-Cholamidopropyl)
dimethylammonio]-2-hydroxy-1-propanesulfonate;
CHS, cholesteryl hemisuccinate; CMC, critical micelle
concentration; DHA, [3H] (-) dihydroalprenolol; DM, n-
decyl-β-D-maltoside; DMPC, L-α-1,2-
dimyristoylphosphatidylcholine; GPCRs, G-protein
coupled receptors; LTB4, leukotriene B4 receptor;
OG, n-octyl-β-D-glucopyranoside; PG, L-
phosphatidyl-D,L-glycerol dipalmitoyl; SDS, sodium
dodecylsulfate; SD, standard deviation; TX, Triton X-
100.
Protein expression and purification
Purified β1AR-m23 was kindly provided by the laboratory of Chris Tate (MRC, Laboratory of
Molecular Biology). The β1AR-m23 construct is truncated at both the N- (residues 3–32) and
C-terminus (after residue Leu367) and contains a C-terminal tag of six histidine residues for
purification. A segment, comprising residues 244–271, is also deleted. The construct contains
eight point mutations: C116L improves expression; C358A at the C-terminus of Helix 8
removes a palmitoylation site; R68S, M90V, Y227A, A282L, F327A and F338A improve ther-
mal stability. The receptor was expressed using the baculovirus system in High 5 cells. Mem-
brane preparation, solubilisation, immobisilied metal ion affinity chromatography (IMAC)
and alprenolol ligand-affinity chromatography were all performed as previously described
[23]. The receptor was purified in buffer containing 20 mM Tris pH 7.8, 350 mMNaCl, 0.2
mM EDTA, 100 nM alprenolol and 0.1% decylmaltoside (DM).
Urea unfolding
Fluorescence and CD unfolding experiments were carried out at room temperature at a final
β1AR-m23 concentration of 0.45 μM (0.0162 mg/ml) and 4.5 μM (0.162 mg/ml). For urea
unfolding experiments in DM, β1AR-m23 was diluted into buffer containing 25 mM Tris pH
7.5, 150 mMNaCl, 0.1 mM EDTA, 0.5% DM and varying concentrations of urea (0–9 M) and
incubated for 30 min with gentle mixing before spectral analysis was carried out. A higher con-
centration of DM was required in unfolding experiments carried out in urea, than SDS, due to
the effects of urea on increasing the cmc of the detergent. Where possible averaged results are
from independent experiments performed using different samples but the same protein prepa-
ration. However, in those experiments requiring large amounts of sample, such as CD, aver-
aged results are sometimes from independent experiments using samples from different
protein preparations. Variations in the CD signal and fluorescence were observed between dif-
ferent preparations of protein, most likely due to errors in determining protein concentration.
Refolding from a urea-denatured state
β1AR-m23 was refolded by immobilisation on a Ni
2+ affinity resin. β1AR-m23 was diluted to
approximately 4.5 μM in 2 ml of DM buffer (25 mM Tris pH 7.5, 150 mMNaCl and 0.5% DM)
and incubated with 1 ml Ni2+-NTA agarose for 1.5 h at 4°C. Ni2+-NTA agarose beads were
recovered by centrifugation and washed with buffer containing 8 M urea for denaturation of
the protein. The beads were again recovered and refolding initiated by washes with 3 x 2 ml of
DM buffer. Refolded β1AR-m23 was eluted in DM buffer containing 300 mM imidazole. For
folded control experiments, the DM buffer was unchanged. For unfolded control experiments,
refolding was not initiated and β1AR-m23 was eluted in DM buffer containing 8 M urea and
300 mM imidazole. The imidazole was removed from all samples using a PDMiniTrap G-25
column (GE Healthcare) and protein concentration determined using the Markwell-Lowry
assay [25]. Refolding of urea-unfolded β1AR-m23 was also attempted by rapid dilution into
DM. β1AR-m23 was unfolded by dilution into 25 mM Tris pH 7.5, 150 mMNaCl, 0.5% DM or
and 8 M urea to a final concentration of 4.5 μM. Following incubation at room temperature for
5 min refolding was initiated by a tenfold dilution into buffer without denaturant and incu-
bated for a further 30 min. The protein signal was too low to be accurately detected following
refolding from a lower protein concentration of 0.45 μM, this was especially true when refold-
ing was carried out using the dilution method where the protein is diluted 10-fold into a rena-
turing buffer.
Reversible Refolding of a G-Protein Coupled Receptor
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Fluorescence spectroscopy
Intrinsic protein fluorescence emission spectra were recorded on a Fluoromax-2 (Jobin Yvon)
at room temperature and in a 10 mm pathlength cell. Samples were excited at 280 nm and
emission spectra collected between 295–450 nm with 1 nm excitation and 5 nm emission band-
widths. Unfolding curves were generated by plotting the red-shift in the fluorescence emission
maximum against denaturant concentration.
Circular dichroism spectroscopy
CD spectra were measured at room temperature between 200–260 nm in 1 nm intervals with a
1 s integration time and a band width of 1 nm. Cells with pathlengths of 5 and 0.5 mm were
used for protein concentrations of 0.45 and 4.5 μM, respectively. Data was analysed using
CDtools software [26] and unfolding curves were generated by plotting the reduction in heli-
city, calculated from changes in the CD signal at the 222 nm band which is characteristic of α-
helical proteins, against denaturant concentration. The 222 nm band was used to monitor fold-
ing due to the absorbance of urea at low wavelengths.
Radioligand binding assays
Saturation binding assays were carried out with [3H](-) dihydroalpenolol essentially as previ-
ously described [27]. Briefly, assays were performed in 25 mM Tris pH 7.5, 150 mMNaCl and
0.5% DM with 60 nM [3H](-) DHA in a final volume of 120 μl which were incubated on ice for
1 h. Bound and free radioligand were then separated by centrifugal gel filtration using columns
packed with 4.4 ml sephadex G-25M (GE Healthcare) pre-equilibrated with DM buffer as
above. Tritiated antagonist was determined by liquid scintillation counting. Non-specific bind-
ing was determined in the presence of 10 μM s-propranolol to folded and unfolded protein
samples and also incubated on ice for 1 h. In urea unfolding experiments measuring the ligand
binding activity of refolded β1AR-m23, binding assays were performed after the refolding pro-
cedure on the Ni2+ affinity resin (see the Materials and Methods above). The activity of the
refolded receptor was compared to that determined of the originally purified receptor that had
not been denatured by urea. In these folded control experiments the receptor was bound to the
column but not treated with urea and instead the DM-buffer remained unchanged. Unfolded
control experiments were also performed in which β1AR-m23 was eluted in 8 M urea. Follow-
ing elution from the column and determination of protein concentration by the Markwell-
Lowry assay, the receptor was diluted to 0.1 μM in the appropriate DM-containing buffer
before addition of 5 μl (~18 ng) to each radioligand binding assay (120 μl total reaction vol-
ume) giving a final receptor concentration of 4.2 nM (with the radioligand being 60 nM).
The ability of β1AR-m23 to bind radioligand following immobilisation and urea unfolding
on a Ni2+ resin was also measured. 4.5 μM β1AR-m23 was bound to Ni
2+-NTA agarose in DM
as previously described in the Materials and Methods. Ni2+-NTA agarose beads were recovered
by centrifugation and unfolding of β1AR-m23 initiated by solvent exchange to buffer contain-
ing 8 M urea. Following 1 min incubation, beads were recovered and resuspended in buffer
containing 8 M urea and 0.6 μM [3H] (-) DHA. Following a further minute incubation, beads
were again recovered and a wash step in 8 M urea performed to remove any unbound radioli-
gand. At the end of the experiment, the beads were recovered, resuspended in 8 M urea and the
radioactivity associated with the beads, and therefore bound to β1AR-m23, measured. It should
be noted that the total unfolding time with 8 M urea was 5 minutes. Control experiments were
also carried out with no protein and with β1AR-m23 but under folding conditions by replacing
buffer containing 8 M urea with buffer in which urea had been omitted.
Reversible Refolding of a G-Protein Coupled Receptor
PLOS ONE | DOI:10.1371/journal.pone.0151582 March 16, 2016 4 / 16
Pulse proteolysis
The use of pulse proteolysis to follow β1AR-m23 unfolding was initially tested in bulk solution
using a 1-min pulse as follows; β1AR-m23 was diluted into buffer containing 25 mM Tris pH
7.5, 150 mMNaCl, 0.5% DM, 10 mM CaCl2 and urea (2–8 M) at a final concentration of
0.45 μM and allowed to equilibrate for 30 min at room temperature. Proteolysis was initiated
by adding a 50x stock solution of thermolysin in 2.5 M NaCl and 10 mM CaCl2 to a final con-
centration of 0.2 mg/ml. After 1 min incubation, the reactions were quenched by the addition
of 13.3 μM phosphoramidon and vortexed. Quenched reactions were analysed on 12% (w/v)
SDS-PAGE stained with SYPRO Red fluorescent dye (Molecular Probes). Band intensities were
quantified with the image analysis software AlphaErase FC. Pulse proteolysis was also used to
monitor β1AR-m23 unfolding on a Ni
2+-NTA column and compared to that in bulk solution.
In these experiments, 0.45 or 4.5 μM β1AR-m23 in either bulk solution or bound to Ni
2+-NTA
agarose beads was incubated in buffer as above containing 3 or 8 M urea for 2 or 27 min (for a
5 or 30 min total unfolding time). Proteolysis was initiated by the addition of thermolysin and
quenched by the addition of phosphoramidon, as above. β1AR-m23 was eluted from Ni
2+-
NTA agarose with 300 mM imidazole and all samples analysed by SDS-PAGE. Also in these
experiments, the length of digestion, both on the column and in bulk solution, was increased to
3 min to compensate for the diminished activity of thermolysin in high concentrations of urea.
Results
Urea unfolding of β1AR-m23 in DM in bulk solution and on a solid
support
Intrinsic protein fluorescence and far-UV circular dichroism (CD) were used to monitor
changes in β1AR-m23 structure in bulk solution in DM and in the presence of the chemical
denaturant urea. Unfolding was assessed by a reduction in helical secondary structure (as
shown by a decrease in the 222 nm CD band characteristic of α helical structure). The change
in tryptophan fluorescence was also monitored during denaturation, as an increase in exposure
of tryptophan residues to water is accompanied by a red-shift in the fluorescence emission
maximum to longer wavelengths. Although the latter fluorescence change cannot necessarily
be linked directly to changes in folded and unfolded state populations.
Dilution of 0.45 μM β1AR-m23 in DM into buffer containing 8 M urea resulted in a protein
fluorescence band that had red-shifted by ~ 9 nm (from 329.9 nm in DM to 339.3 nm in urea)
(Fig 1a). Under the same conditions a decrease in intensity of the 222 nm CD band, from ~
-26,070 deg.cm2.dmol-1 to -10,480 deg.cm2.dmol-1, was observed corresponding to a loss of
~60% of its starting α-helix (Fig 1b). Plots of the red-shift in the fluorescence emission maxi-
mum correlated with those for reduction in helicity against urea concentration. These fluores-
cence and CD data exhibit similar midpoints of unfolding, Cm, centred around 4.0 ± 0.1 M and
4.5 ± 0.1 M, respectively, and similar slopes at the Cm of 0.90 ± 0.07 nmM
-1 and 0.82 ± 0.06%
reduction in helicityM-1, respectively (S1a, S1b and S2 Figs). Unfolding was also carried out at
a 10-fold higher protein concentration (4.5 μM) (Fig 1c and 1d). Under these conditions the
receptor loses ~47% of its starting α-helix (Fig 1d).
Urea unfolding of β1AR-m23 in DM was also assessed on a solid support by binding to an
affinity resin composed of Ni2+-NTA agarose beads by virtue of a His tag. As the beads caused
light scattering artefacts in the spectroscopic measurements described above; pulse proteolysis
was employed to monitor structural changes in the immobilised receptor in the presence of
urea. Pulse proteolysis exploits differences in proteolytic susceptibility between folded and
unfolded proteins [28, 29]. Following unfolding, proteolysis is performed briefly allowing
Reversible Refolding of a G-Protein Coupled Receptor
PLOS ONE | DOI:10.1371/journal.pone.0151582 March 16, 2016 5 / 16
digestion of unfolded protein while keeping folded protein intact. The fraction of folded pro-
tein can then be quantified by SDS-PAGE and plotted against denaturant concentration to
determine Cm. The validity of this method for monitoring β1AR-m23 unfolding in urea was ini-
tially tested in bulk solution using a 1 min pulse. The SDS-PAGE in Fig 2a shows the amount
of folded receptor remaining in varying urea concentrations following 1-min pulse proteolysis
with thermolysin. β1AR-m23 remains largely intact in 2–3 M urea (folding conditions) with
band intensities comparable to that of undigested receptor. In higher urea concentrations (3–7
M) the fraction of folded receptor decreases, as demonstrated by the disappearance of the intact
protein band and appearance of lower molecular weight cleavage products. In 7 M urea and
above the intact protein band begins to reappear, probably due to the reduced activity of ther-
molysin in high urea [28, 30]. The Cm value obtained by pulse proteolysis (4.3 ± 0.1 M with an
associated slope of 0.4 ± 0.1% folded proteinM-1) is in excellent agreement with that deter-
mined by fluorescence and far-UV CD (Fig 2b and Table 1). It should be noted, that in the
complete absence of urea some folded β1AR-m23 was digested. Although this could be over-
come by adding less protease this also reduced the sensitivity of the assay.
Fig 1. β1AR-m23 unfolding in DM and in urea. Fluorescence and far UV CD spectra (a and b, respectively) of 0.45 μM and (c and d, respectively) 4.5 μM
β1AR-m23 in DM in the original folded state in the presence of 0 M urea (solid lines) and 3 M urea (dashed lines), and unfolded in 8 M urea (dotted lines). All
buffers contained 25 mM Tris pH 7.5, 150 mMNaCl, 0.1 mM EDTA and 0.5% DM. Spectra are averages from a minimum of three independent experiments
on different samples. For folded protein (in 0 M urea) the band intensity at 222 nm was -26070 ± 2400 deg.cm2.dmol-1 and -27780 ± 5400 deg.cm2.dmol-1 at a
protein concentration of 0.45 μM and 4.5 μM, respectively. The wavelength at the fluorescence emission maximum for folded protein was 329.9 ± 0.8 nm and
329.8 ± 0.3 nm at a protein concentration of 0.45 μM and 4.5 μM, respectively. The intensity at the fluorescence emission maximum for folded protein was
474000 ± 118000 and 2404000 ± 399000 at a protein concentration of 0.45 μM and 4.5 μM, respectively.
doi:10.1371/journal.pone.0151582.g001
Reversible Refolding of a G-Protein Coupled Receptor
PLOS ONE | DOI:10.1371/journal.pone.0151582 March 16, 2016 6 / 16
Pulse proteolysis was also used to monitor β1AR-m23 unfolding on a Ni
2+-NTA column
and compared to that in bulk solution. The length of digestion was increased to 3 min to com-
pensate for the diminished activity of the protease in 8 M urea (used for unfolding). Following
equilibration of 4.5 μM β1AR-m23 on a solid support under folding (3 M urea) or unfolding
Fig 2. Monitoring β1AR-m23 unfolding in bulk solution by pulse proteolysis. 0.2 mg/ml thermolysin was used to digest 0.45 μM β1AR-m23, pre-
equilibrated in buffer containing 25 mM Tris pH 7.5, 150 mMNaCl, 0.1 mM EDTA, 0.5% DM, 10 mMCaCl2 and urea (2–8 M) for 30 min, for 1 min. (a) A
representative SDS-PAGE gel of β1AR-m23 following 1-min pulse proteolysis. (b) The percentage of folded β1AR-m23 remaining as determined by pulse
proteolysis (circles), fluorescence (squares) and far-UV CD (triangles). The percentage of folded protein at each urea concentration was determined by;
pulse proteolysis from the amount of undigested protein as measured by SDS-PAGE; fluorescence from the red-shift in the fluorescence emission maximum;
and CD from the degree of α-helical structure as measured by the CD intensity at 222 nm. Resulting values were normalised between 0% and 100% with
100% representing the fully folded protein in DM and the 0% the partly unfolded 8 M urea state that possesses some helical content. Error bars show ± SD
(standard deviation) and are the result of a minimum of three independent experiments on different samples.
doi:10.1371/journal.pone.0151582.g002
Reversible Refolding of a G-Protein Coupled Receptor
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conditions (8 M urea), as judged by bulk solution fluorescence and CD experiments (Fig 1c
and 1d), clear differences in proteolytic susceptibility were observed; after a 5 min incubation
in urea 60.3 ± 10.7% of the amount of receptor present in 3 M urea remained intact in 8M urea
(Fig 3 and Table 2). The concentration of thermolysin used in these proteolysis experiments (~
6 μM) was similar to that of the receptor meaning unfolded protein is likely to be digested
slower than in conditions of an excess of protease. Experiments performed with higher concen-
trations of protease or with longer digestion periods resulted in greater problems with digestion
of folded protein (data not shown). However, when the experiments were carried out with
10-fold less protein (0.45 μM), ensuring an excess of protease, greater difference in proteolytic
susceptibility were observed in 3 and 8 M urea; only 41.5 ± 5.1% of the amount of receptor in 3
Table 1. Cm values for 0.45 μM β1AR-m23 unfolded in urea as determined by 1-min pulse proteolysis,
fluorescence and circular dichroism.
Cm [M] Slope [% folded protein M-1]
Pulse proteolysis 4.3 ± 0.1 0.4 ± 0.1
Fluorescence 4.0 ± 0.4 0.9 ± 0.2
Circular dichroism 4.5 ± 0.3 0.8 ± 0.1
Cm values for 0.45 μM β1AR-m23 unfolded in urea as determined by 1-min pulse proteolysis, ﬂuorescence
and circular dichroism. Unfolding curves in Fig 2 were ﬁt to determine the denaturant concentration at the
midpoint of unfolding (Cm) together with the slope at the Cm. Errors are ± SD and are the result of a
minimum of 3 independent experiments on different samples.
doi:10.1371/journal.pone.0151582.t001
Fig 3. Comparing β1AR-m23 unfolding in bulk solution and on a solid support by pulse proteolysis. Example SDS-PAGE gels of β1AR-m23 following
3-min pulse proteolysis after a 5 or 30 min incubation in urea. Briefly, 0.45 or 4.5 μM β1AR-m23 in either bulk solution or bound to Ni
2+-NTA column was
equilibrated with buffer containing 25 mM Tris pH 7.5, 150 mMNaCl, 0.1 mM EDTA, 0.5% DM, 10 mMCaCl2 and 3 (folding conditions) or 8 M (unfolding
conditions) urea followed by digestion with 0.2 mg/ml thermolysin for 3 min. The original folded β1AR-m23 is shown for comparison (lanes β1AR-m23) and
molecular mass markers are indicated in kDa (lanes M).
doi:10.1371/journal.pone.0151582.g003
Reversible Refolding of a G-Protein Coupled Receptor
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M urea remained intact in 8 M urea (Fig 3 and Table 2). β1AR-m23 unfolding on the column is
further supported by its inability to bind [3H] (-) dihydroalprenolol (DHA) following incuba-
tion in 8 M urea (S4 Fig).
Reversible folding of β1AR-m23 in DM from a urea-denatured state
4.5 μM β1AR-m23 in 8 M urea, which has lost a significant amount (~47%) of its starting α-
helical structure was used for refolding experiments (Fig 1d). Successful refolding was primar-
ily assessed by recovery of ligand binding activity; to that of the purified receptor prior to
unfolding. Recovery of the CD and fluorescence spectra to that of the original purified state
was also used. Refolding was attempted into DM by two methods: (i) on a solid support using a
Ni2+-NTA affinity column and (ii) in bulk solution by rapid dilution.
β1AR-m23 refolding on a solid support by removal of urea on a Ni
2+-NTA affinity column
was determined to be very efficient with recovery of approximately 100% of functional protein,
as determined by the recovery of approximately 100% of the original binding activity, to the
antagonist [3H]DHA, as compared to that of the originally folded receptor in DM prior to any
treatment with urea (Fig 4a). As the predicted molecular weight of our receptor construct is 36
kDa, the theoretical maximum specific binding for pure receptor is 27.8 nmol/mg protein,
assuming one binding site per receptor. Ligand binding values of 10.8 ± 1.9 nmol/mg were
obtained for the original folded β1AR-m23 in DM, which corresponded to ~ 40% of the theo-
retical maximum. This is comparable to previously reported ligand binding values obtained for
truncated β1AR (βAR 34-424/His6) of between 10–12 nmol/mg [27]. The ligand binding activ-
ity of the refolded β1AR-m23 was 10.5 ± 2.5 nmol/mg. Tryptophan fluorescence and far-UV
CD spectra also returned to that of the originally folded receptor in DM (Fig 4b–4e).
Dilution of β1AR-m23 into various DM-containing buffers resulted in incomplete refolding
as judged by the lack of recovery of the original fluorescence band; the fluorescence emission
maximum after dilution of 335.2 nm was only slightly shifted from the urea-unfolded state at
337.8 nm, and did not fully recover to the 329.9 nm maximum of the originally folded receptor
in DM (S5 Fig). This difference is too large to be attributed to the small amount (0.8 M) of urea
remaining in these samples as demonstrated by unfolding experiments in which urea concen-
trations greater than 4 M are required to induce such changes in the fluorescence emission
maximum or CD signal at 222 nm (S1a and S1b Fig).
Discussion
An in depth knowledge of the structural and molecular basis of GPCR function is lacking,
often owing to difficulties in their overexpression, purification and stabilisation. It is therefore
Table 2. The band intensities of intact β1AR-m23 on SDS-PAGE gels following 3-min pulse proteolysis in urea.
0.45 μM β1AR-m23 4.5 μM β1AR-m23
5 min 30 min 5 min 30 min
Bulk solution 28.8 ± 7.5 31.3 ± 4.1 56.4 ± 11.8 42.1 ± 5.1
Ni-NTA beads 41.5 ± 5.1 40.2 ± 6.9 60.3 ± 10.7 59.8 ± 10.5
The band intensities of intact β1AR-m23 on SDS-PAGE gels following 3-min pulse proteolysis in 3 M (folding conditions) or 8 M (unfolded conditions) urea
(Fig 3) were calculated using the AlphaErase FC software. Values given are the percentage amounts of intact β1AR-m23 remaining in 8 M (unfolded
conditions) compared to in 3 M (folded conditions) urea. Each value is the result of an average of between 5 to 9 independent measurements on different
samples; errors are ± SD.
doi:10.1371/journal.pone.0151582.t002
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crucial to develop new and efficient methodologies for obtaining large amounts of native-like,
functional and stable GPCRs. Here, we address a fundamental facet of GPCR function, their
folding, and report the functional folding (in terms of ligand binding and secondary structure)
of the exemplary GPCR, β1AR-m23, from a chemically-denatured state. This has provided
important insights into how to obtain and stabilise the correct fold of the receptor. Firstly, the
Fig 4. β1AR-m23 refolding on a Ni
2+-NTA column into DM, from urea. 4.5 μM β1AR-m23, bound to a Ni
2+-NTA column, was unfolded in 25 mM Tris pH
7.5, 150 mMNaCl, 0.5% DM and 8 M urea for 5 mins before refolding into buffer in which the urea had been omitted. The (a) binding of antangonist [3H]DHA
to as well as the (b) fluorescence emission maximum and (d) CD signal at 222 nm of the refolded receptor. Results are compared to the originally folded
β1AR-m23 in 0.5% DM and β1AR-m23 unfolded in 8 M urea. Error bars show ± SD and are the result of three independent experiments on different samples.
(c) Fluorescence and (e) far UV-CD spectra of the original folded β1AR-m23 in 0.5% DM (solid line) and of refolded β1AR-m23 in 0.5% DM (dotted line).
Spectra are the average of three independent measurements. The fluorescence emission maximumwas 330.7 ± 0.5 nm for the original folded receptor and
331.7 ± 0.7 nm for the receptor refolded in DM. The CD signal at 222 nm was– 21520 ± 2840 deg.cm2.dmol-1 for the original folded receptor and–
21360 ± 2520 deg.cm2.dmol-1.
doi:10.1371/journal.pone.0151582.g004
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most stabilising conditions for the isolated receptor, are not necessarily the best for folding;
although bicelles containing the lipid DMPC were found to be the most stabilising conditions
for β1AR-m23 (S2 and S3 Figs), no refolding occurred in any of the bicelle conditions tested
but only in DM detergent micelles. Secondly, the extent of helical perturbations in the dena-
tured state is not a good indication of the likelihood of successful refolding; β1AR-m23 cannot
be fully refolded from an SDS-denatured state even though SDS induces fewer perturbations in
helical structure than in urea. At 4.5 μM β1AR-m23 loses 34% of its starting α-helical structure
in SDS compared to 47% in urea (S6d Fig) however, only ~ 36% of the original binding activity
is restored upon refolding from this SDS denatured state on a Ni2+-NTA column (S7c Fig). We
show that the complete refolding of β1AR-m23 is achieved into DMmicelles, from a urea-
denatured state, using an affinity column as a solid support. One possibility is that compared
to refolding in bulk solution, a solid support is advantageous in preventing unwanted protein/
protein interactions that favour aggregation. We cannot however, rule out other contributions
for example electrostatic effects of the solid surface which may aid in protein folding. Practi-
cally, this work provides the groundwork for obtaining stable, functional GPCRS for further
structural and functional characterisation.
Although there are only a limited number of examples of refolding studies with GPCRs, the
use of columns in recovering functional GPCRs from inclusion bodies solubilised in harsh
detergents such as SDS and urea has been reported previously [15–19]. However, no detailed
structural information of the denaturant-solubilised state exists, nor has complete refolding
and recovery of a native-like state been demonstrated; the leukotriene B4 (LTB4) receptor,
BLT1, has been functionally folded into detergent-lipid mixed micelles composed of LDAO-
asolectin with folding yields of ~ 20–30% (defined as the ratio of the amount of functional pro-
tein obtained after dissociation from the column to that initially immobilised, as determined
by the affinity constant for LTB4 binding) [15, 18]; the serotonin receptor, 5-HT4a was folded
into the functional conformation in DMPC/CHAPS bicelles with folding yields of ~25%
(defined as the ratio of the amount of soluble protein obtained after dissociation from the col-
umn to that initially immobilised. Refolding was also assessed at a qualitative level by analysing
it’s ligand-binding properties) [17]; the olfactory OR5 receptor was first folded into digitonin
detergent micelles with folding yields of ~ 80%, as judged by fluorescence-monitored ligand
binding assays, before insertion into lipid vesicles [16]. In all these cases the protein was recov-
ered from insoluble inclusion bodies. A similar column-assisted folding approach has also been
employed to refold several other membrane proteins from inclusion bodies including the chlo-
roplast protein-import channel, Toc 75, and the light harvesting complex II (LHC2). In both
cases, the solubilised inclusion bodies were applied to the Ni2+ column and refolding initiated
by buffer exchange from chaotrope to mild detergent; Triton X-100 (TX) for Toc 75 and n-
octyl-β-D-glucopyranoside (OG) for LHC2. In the case of LHC2, this was followed by pigment
binding and trimerisation upon transfer to mixed lipid-detergent micelles composed of TX and
L-phosphatidyl-D,L-glycerol dipalmitoyl (PG) [31]. Refolding yields of 8% and 3% are
reported, for Toc 75 and LHC2, respectively. Neither of these proteins could be refolded by
dilution of the unfolded protein into detergent micelles or lipids. Here, β1AR-m23 is refolded
from a urea-denatured state with known perturbations in both secondary and tertiary structure
as well as abolition of ligand binding. Noteworthy, is that our folding studies are carried out
under non-reducing conditions and thus the starting material for refolding also contains the
two native disulphide bonds between the correct cysteine residues (C114-C199, and C192
-C198). Previous work on rhodopsin has shown that misfolding was caused by the formation
of a disulphide bond different from that in native rhodopsin [32]. This level of structural infor-
mation is important if we are to gain a more detailed understanding of GPCR folding mecha-
nisms. Moreover, we achieve complete, 100% recovery of ligand binding activity as compared
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to that of untreated receptor which has not been unfolded, which is vital given the tendency of
GPCR stability and ligand binding to be disrupted when solubilised in detergents in vitro. To
our knowledge, this is the first example of such a highly efficient and truly reversible folding
system for a GPCR.
The efficiency of β1AR-m23 refolding on the beads from urea was found to be dependent on
the initial unfolding time in urea; with higher refolding yields obtained following shorter
unfolding times in urea (over the range of 5 to 60 min), as judged by the recovery of protein
fluorescence and ligand binding activity (S8 Fig). 100% refolding yields with complete recovery
of helical structure, protein fluorescence and ligand binding, as compared to the receptor in
DM prior to any urea treatment, were only observed following 5 min unfolding in urea. Longer
unfolding times of 10, 30 and 60 min caused the refolding yields to drop to 90, 72 and 30%,
respectively. We used pulse proteolysis combined with electrophoresis to monitor structural
changes in β1AR-m23 on the column after unfolding in urea for 5 and 30 min. Comparisons of
protein band intensities in unfolding (8 M) and folding (3 M) urea concentrations showed the
percentage amount of intact receptor remaining in unfolding conditions compared to folding
conditions; 60.3 ± 10.7% and 59.8 ± 10.5% of the of the intact protein remained after 5 and 30
min unfolding, respectively (Fig 3 and Table 2), thus implying no further unfolding with a lon-
ger unfolding time than 5 min.
Interestingly, β1AR-m23 cannot be fully refolded from an SDS-denatured state. Previous
reports have found recovery of functional GPCRs from SDS-solubilised inclusion bodies.
Much lower yields have been reported for obtaining functional GPCRs from urea-solubilised
inclusion bodies Work by Rogl et al. reporting on the refolding of Toc75 from bacterial inclu-
sion bodies also suggests that inclusion bodies are more resistant to unfolding compared to
their folded counterparts; tryptophan fluorescence spectroscopy was used to show that the
unfolded inclusion bodies had an emission peak that was intermediate (346 nm) to that of
folded Toc 75 (342 nm) and the same sample unfolded in urea (353 nm) [31]. Our more
defined folding system seems to be the key to achieving higher refolding yields and may be
applicable to other GPCRs, as well as for membrane proteins in general.
Although our understanding of the various factors affecting the folding yields of GPCRs is
still somewhat limited, our results support the idea that preventing aggregation through the
formation of intermolecular protein interactions, facilitates folding. This can be achieved by
carrying out folding with the receptor immobilised on a solid support, for example on a Ni2+
affinity resin if the protein carries a His-tag and by limiting the length of time that the receptor
is in denaturant. Given the large variation in GPCR folding environments reported, it may be
that the choice of this environment is specific to each receptor in which case the most straight-
forward strategy is to systematically test a range of folding conditions and quantify the associ-
ated refolding yields, as demonstrated here.
Supporting Information
S1 Appendix. Supporting Methods and Results.
(DOCX)
S1 Fig. β1AR-m23 unfolding in DM-containing buffers. Fluorescence and far-UV CD were
used to monitor unfolding in the presence of urea and SDS and various conditions screened in
their ability to improve the resistance of the receptor against denaturation. Plots of the red-
shift in the fluorescence emission maximum (λmax) versus concentration of (a) urea and (c)
SDS and plots of the reduction in helicity versus concentration of (b) urea and (d) SDS are
shown. The reduction in helicity is determined from the reduction in CD signal at 222 nm.
Unfolding was carried out at a β1AR-m23 concentration of either 0.45 μM or 4.5 μM in buffers
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containing 25 mM Tris pH 7.5, 150 mMNaCl, 0.1 mM EDTA, 0.5% DM and varying concen-
trations of urea (0–9 M), unless stated otherwise, for 30 min. Plots show unfolding under the
following conditions; at a final protein concentration of 0.45 μM (open circles, solid line) and
at the same protein concentration but in the presence of 350 mMNaCl (open squares, dashed
line), 10% (w/v) glycerol (open triangles, dotted line), 0.02% (w/v) CHS (closed circles, solid
line) and 1 μM alprenolol (solid squares, dashed line) and at a final protein concentration of
4.5 μM (solid triangles, dotted line). Error bars show ± SD.
(TIF)
S2 Fig. Fluorescence- and CD-measured Cm values for β1AR-m23 unfolding in urea and
SDS.
(TIF)
S3 Fig. β1AR-m23 unfolding in DMPC/CHAPS. Plots of the red-shift in the fluorescence
emission maximum (λmax) versus concentration of (a) urea and (b) SDS. Unfolding was per-
formed at a final receptor concentration of 0.45 μM in bicelles of varying q values; 0.49 (open
circles), 0.91 (open squares), 1.68 (open triangles), 2.73 (closed circles) and 3.63 (closed
squares), or in DM (closed triangles). All buffers contained 2% (w/v total lipid and detergent)
DMPC/CHAPS, 25 mM Tris pH 7.5, 150 mMNaCl and 0.1 mM EDTA. Error bars show ± SD.
(TIF)
S4 Fig. Binding activity of β1AR-m23 on a Ni
2+ -NTA column. The amount of radioligand
bound to 4.5 μM β1AR-m23 on a Ni
2+ -NTA column following 5 min incubation with buffer
containing 25 mM Tris pH 8, 150 mMNaCl, 0.1 mM EDTA, 0.5% DM and 8 M urea
(unfolded). Results are compared to control experiments carried out with no protein (no pro-
tein) and with β1AR-m23 but under folding conditions in the absence of urea (native). Error
bar show ± SD and are the result of a minimum of four independent experiments on different
samples.
(TIF)
S5 Fig. Refolding β1AR-m23 by dilution into DM, from urea. Changes in the fluorescence
emission maximum of β1AR-m23 initially unfolded at 4.5 μM in 8 M urea for 5 min and then
diluted 10-fold into various DM-containing buffers all containing 25 mM Tris pH 7.5, 150 mM
NaCl and 0.5% DM. Comparisons with that of the original folded β1AR-m23 in 0.5% DM and
unfolded β1AR-m23 in 8 M urea are shown. Error bars show ± SD and are the result of three or
four independent experiments on different samples.
(TIF)
S6 Fig. β1AR-m23 unfolding in DM and in SDS. Fluorescence and far-UV CD spectra of (a
and b, respectively) 0.45 μM and (c and d, respectively) 4.5 μM β1AR-m23 in 25 mM Tris pH
7.5, 150 mMNaCl, 0.1 mM EDTA and 0.2% DM in the original folded state in the absence of
SDS (solid lines) and unfolded in 0.84 XSDS (~0.65% SDS) (dotted lines). Fluorescence and CD
spectra show the results from a single measurement. For folded protein (in 0 XSDS) the CD sig-
nal at 222 nm was -18990 deg.cm2.dmol-1 and– 21530 deg.cm2.dmol-1 at a protein concentra-
tion of 0.45 μM and 4.5 μM, respectively. The wavelength at the fluorescence emission was
330.4 nm and 328. 5 nm at a protein concentration of 0.45 μM and 4.5 μM, respectively. The
intensity at the fluorescence emission maximum was 516000 and 3404000 at a protein concen-
tration of 0.45 μM and 4.5 μM, respectively. Folding experiments with SDS were carried out
using a different protein preparation to those carried out with urea and were not pursued in
great depth due to more successful refolding results achieved with urea.
(TIF)
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S7 Fig. Refolding β1AR-m23 into DM, from SDS. Refolding of 4.5 μM β1AR-m23 was per-
formed following a 5 min incubation with 25 mM Tris pH 7.5, 150 mMNaCl, 0.1 mM EDTA,
0.2% DM and 0.84 XSDS (0.65% SDS) in bulk solution, by rapid dilution or on a Ni
2+-NTA col-
umn. (a) Fluorescence emission maxima of β1AR-m23 diluted 10-fold into various DM-con-
taining buffers. (b) Fluorescence emission maxima and (c) binding of antagonist [3H](-)DHA
to β1AR-m23 refolded on a column. Comparisons with that of original folded β1AR-m23 in
0.2% DM and unfolded β1AR-m23 in 0.84 XSDS are shown. Error bars show ± SD and are the
result of two or three independent experiments on different samples.
(TIF)
S8 Fig. β1AR-m23 refolded on a Ni
2+-NTA column into DM, from urea, over time. Changes
in the intrinsic protein fluorescence and ligand binding activity of β1AR-m23 were measured as
follows: (a) The fluorescence emission maximum (b) and binding of antagonist [3H]DHA of
β1AR-m23 refolded into 25 mM Tris pH 7.5, 150 mMNaCl, 0.5% DM after a 5, 10, 30 and 60
min incubation with 8 M urea at a protein concentration of 4.5 μM. Results are compared to
original folded β1AR-m23 in 0.5% DM and unfolded β1AR-m23 denatured in 8 M urea. Error
bars show ± SD and are the result of two or three independent experiments on different samples.
(TIF)
Author Contributions
Conceived and designed the experiments: NDB PJB ELRC GFXS. Performed the experiments:
NDB ELRC. Analyzed the data: NDB. Contributed reagents/materials/analysis tools: TW PCE
CGT GFXS. Wrote the paper: NDB PJB.
References
1. Miller D, Charalambous K, Rotem D, Schuldiner S, Curnow P, Booth PJ. In vitro unfolding and refolding
of the small multidrug transporter EmrE. Journal of molecular biology. 2009; 393(4):815–32. Epub
2009/08/25. doi: 10.1016/j.jmb.2009.08.039 PMID: 19699749.
2. Harris NJ, Findlay HE, Simms J, Liu X, Booth PJ. Relative Domain Folding and Stability of a Membrane
Transport Protein. Journal of molecular biology. 2014; 426(8):1812–25. doi: 10.1016/j.jmb.2014.01.012
PMID: 24530957
3. Findlay HE, Rutherford NG, Henderson PJ, Booth PJ. Unfolding free energy of a two-domain trans-
membrane sugar transport protein. Proceedings of the National Academy of Sciences of the United
States of America. 2010; 107(43):18451–6. Epub 2010/10/13. doi: 10.1073/pnas.1005729107 PMID:
20937906; PubMed Central PMCID: PMCPmc2972933.
4. Bartlett AI, Radford SE. An expanding arsenal of experimental methods yields an explosion of insights
into protein folding mechanisms. Nature structural & molecular biology. 2009; 16(6):582–8. Epub 2009/
06/06. doi: 10.1038/nsmb.1592 PMID: 19491935.
5. Curnow P, Di Bartolo ND, Moreton KM, Ajoje OO, Saggese NP, Booth PJ. Stable folding core in the
folding transition state of an alpha-helical integral membrane protein. Proceedings of the National Acad-
emy of Sciences of the United States of America. 2011; 108(34):14133–8. Epub 2011/08/13. doi: 10.
1073/pnas.1012594108 PMID: 21831834; PubMed Central PMCID: PMCPmc3161581.
6. Daggett V, Fersht A. The present view of the mechanism of protein folding. Nat Rev Mol Cell Biol. 2003;
4(6):497–502. PMID: 12778129
7. Sachse R, Dondapati SK, Fenz SF, Schmidt T, Kubick S. Membrane protein synthesis in cell-free sys-
tems: From bio-mimetic systems to bio-membranes. FEBS letters. 2014; 588(17):2774–81. doi: 10.
1016/j.febslet.2014.06.007 PMID: 24931371
8. Ezure T, Nanatani K, Sato Y, Suzuki S, Aizawa K, Souma S, et al. A cell-free translocation system
using extracts of cultured insect cells to yield functional membrane proteins. PloS one. 2014; 9(12):
e112874. Epub 2014/12/09. doi: 10.1371/journal.pone.0112874 PMID: 25486605; PubMed Central
PMCID: PMCPmc4259328.
9. van Klompenburg W, Ridder AN, van Raalte AL, Killian AJ, von Heijne G, de Kruijff B. In vitro mem-
brane integration of leader peptidase depends on the Sec machinery and anionic phospholipids and
can occur post-translationally. FEBS letters. 1997; 413(1):109–14. Epub 1997/08/11. PMID: 9287126.
Reversible Refolding of a G-Protein Coupled Receptor
PLOS ONE | DOI:10.1371/journal.pone.0151582 March 16, 2016 14 / 16
10. SkachWR. The expanding role of the ER translocon in membrane protein folding. The Journal of cell
biology. 2007; 179(7):1333–5. Epub 2008/01/02. doi: 10.1083/jcb.200711107 PMID: 18166647;
PubMed Central PMCID: PMCPmc2373491.
11. Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, Babu MM. Molecular signatures of G-
protein-coupled receptors. Nature. 2013; 494(7436):185–94. Epub 2013/02/15. doi: 10.1038/
nature11896 PMID: 23407534.
12. Mason JS, Bortolato A, Congreve M, Marshall FH. New insights from structural biology into the drugg-
ability of G protein-coupled receptors. Trends in pharmacological sciences. 2012; 33(5):249–60. Epub
2012/04/03. doi: 10.1016/j.tips.2012.02.005 PMID: 22465153.
13. Kobilka BK, Deupi X. Conformational complexity of G-protein-coupled receptors. Trends in pharmaco-
logical sciences. 2007; 28(8):397–406. Epub 2007/07/17. doi: 10.1016/j.tips.2007.06.003 PMID:
17629961.
14. KroezeWK, Sheffler DJ, Roth BL. G-protein-coupled receptors at a glance. Journal of cell science.
2003; 116(Pt 24):4867–9. Epub 2003/11/20. doi: 10.1242/jcs.00902 PMID: 14625380.
15. Baneres JL, Martin A, Hullot P, Girard JP, Rossi JC, Parello J. Structure-based analysis of GPCR func-
tion: conformational adaptation of both agonist and receptor upon leukotriene B4 binding to recombi-
nant BLT1. Journal of molecular biology. 2003; 329(4):801–14. Epub 2003/06/06. PMID: 12787679.
16. Kiefer H, Krieger J, Olszewski JD, Von Heijne G, Prestwich GD, Breer H. Expression of an olfactory
receptor in Escherichia coli: purification, reconstitution, and ligand binding. Biochemistry. 1996; 35
(50):16077–84. Epub 1996/12/17. doi: 10.1021/bi9612069 PMID: 8973178.
17. Baneres JL, Mesnier D, Martin A, Joubert L, Dumuis A, Bockaert J. Molecular characterization of a puri-
fied 5-HT4 receptor: a structural basis for drug efficacy. The Journal of biological chemistry. 2005; 280
(21):20253–60. Epub 2005/03/19. PMID: 15774473.
18. Baneres JL, Popot JL, Mouillac B. New advances in production and functional folding of G-protein-cou-
pled receptors. Trends in biotechnology. 2011; 29(7):314–22. Epub 2011/04/19. doi: 10.1016/j.tibtech.
2011.03.002 PMID: 21497924.
19. Dahmane T, Damian M, Mary S, Popot JL, Baneres JL. Amphipol-assisted in vitro folding of G protein-
coupled receptors. Biochemistry. 2009; 48(27):6516–21. Epub 2009/06/19. doi: 10.1021/bi801729z
PMID: 19534448.
20. Lau FW, Bowie JU. A method for assessing the stability of a membrane protein. Biochemistry. 1997; 36
(19):5884–92. Epub 1997/05/13. doi: 10.1021/bi963095j PMID: 9153430.
21. Barrera FN, Renart ML, Poveda JA, de Kruijff B, Killian JA, Gonzalez-Ros JM. Protein self-assembly
and lipid binding in the folding of the potassium channel KcsA. Biochemistry. 2008; 47(7):2123–33.
Epub 2008/01/22. doi: 10.1021/bi700778c PMID: 18205389.
22. Barrera FN, Renart ML, Molina ML, Poveda JA, Encinar JA, Fernandez AM, et al. Unfolding and refold-
ing in vitro of a tetrameric, alpha-helical membrane protein: the prokaryotic potassium channel KcsA.
Biochemistry. 2005; 44(43):14344–52. Epub 2005/10/26. doi: 10.1021/bi050845t PMID: 16245951.
23. Warne T, Serrano-Vega MJ, Tate CG, Schertler GF. Development and crystallization of a minimal ther-
mostabilised G protein-coupled receptor. Protein expression and purification. 2009; 65(2):204–13.
Epub 2009/03/20. PMID: 19297694.
24. Serrano-Vega MJ, Magnani F, Shibata Y, Tate CG. Conformational thermostabilization of the beta1-
adrenergic receptor in a detergent-resistant form. Proceedings of the National Academy of Sciences of
the United States of America. 2008; 105(3):877–82. Epub 2008/01/15. doi: 10.1073/pnas.0711253105
PMID: 18192400; PubMed Central PMCID: PMC2242685.
25. Markwell MAK, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify pro-
tein determination in membrane and lipoprotein samples. Analytical biochemistry. 1978; 87(1):206–10.
doi: 10.1016/0003-2697(78)90586-9 PMID: 98070
26. Lees JG, Smith BR, Wien F, Miles AJ, Wallace BA. CDtool-an integrated software package for circular
dichroism spectroscopic data processing, analysis, and archiving. Analytical biochemistry. 2004; 332
(2):285–9. Epub 2004/08/25. doi: 10.1016/j.ab.2004.06.002 PMID: 15325297.
27. Warne T, Chirnside J, Schertler GF. Expression and purification of truncated, non-glycosylated turkey
beta-adrenergic receptors for crystallization. Biochimica et biophysica acta. 2003; 1610(1):133–40.
Epub 2003/02/15. PMID: 12586387.
28. Park C, Marqusee S. Pulse proteolysis: a simple method for quantitative determination of protein stabil-
ity and ligand binding. Nature methods. 2005; 2(3):207–12. Epub 2005/03/23. doi: 10.1038/nmeth740
PMID: 15782190.
29. Park C, Marqusee S. Quantitative determination of protein stability and ligand binding by pulse proteoly-
sis. Current protocols in protein science / editorial board, John E Coligan [et al]. 2006; Chapter 20:Unit
20 11. Epub 2008/04/23. doi: 10.1002/0471140864.ps2011s46 PMID: 18429306.
Reversible Refolding of a G-Protein Coupled Receptor
PLOS ONE | DOI:10.1371/journal.pone.0151582 March 16, 2016 15 / 16
30. Park C, Marqusee S. Probing the high energy states in proteins by proteolysis. Journal of molecular
biology. 2004; 343(5):1467–76. Epub 2004/10/20. doi: 10.1016/j.jmb.2004.08.085 PMID: 15491624.
31. Rogl H, Kosemund K, Kuhlbrandt W, Collinson I. Refolding of Escherichia coli produced membrane
protein inclusion bodies immobilised by nickel chelating chromatography. FEBS letters. 1998; 432(1–
2):21–6. Epub 1998/08/26. PMID: 9710243.
32. Hwa J, Klein-Seetharaman J, Khorana HG. Structure and function in rhodopsin: Mass spectrometric
identification of the abnormal intradiscal disulfide bond in misfolded retinitis pigmentosa mutants. Pro-
ceedings of the National Academy of Sciences of the United States of America. 2001; 98(9):4872–6.
Epub 2001/04/26. doi: 10.1073/pnas.061632798 PMID: 11320236; PubMed Central PMCID:
PMCPmc33130.
Reversible Refolding of a G-Protein Coupled Receptor
PLOS ONE | DOI:10.1371/journal.pone.0151582 March 16, 2016 16 / 16
